Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shisiwei Lingniujiao Wan is a traditional Tibetan medicine (TTM) manufactured by Xizang Ganlu Tibetan Medicine. It is formulated as an oral pill containing fourteen distinct ingredients, with the horn of the takin (*Budorcas taxicolor*) serving as a key component. In the framework of Tibetan medicine, it is primarily used to clear heat and detoxify the body, specifically targeting 'hot' disorders of the lungs and liver. Clinical indications include the treatment of pneumonia, bronchitis, and febrile illnesses characterized by symptoms such as high fever, persistent cough, and chest pain. The product is officially approved in China under the National Drug License Number Z20023193.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shisiwei Lingniujiao Wan.